Setri Fugar
Setri Fugar has a total of 97 co-authors. Here are the top co-authors by number of shared publications:
- Alexis Kofi Okoh
Division of Cardiology, Emory University School of Medicine, Atlanta, GA 30322, USA
4 shared publications Alexis K. Okoh
Northside Hospital Heart Institute, Atlanta, GA (A.K.O.).
3 shared publications- Ahmed A. Kolkailah
Division of Cardiology, Department of Internal Medicine University of Texas Southwestern Medical Center Dallas Texas USA
2 shared publications - Ebru Öztürk
Department of Biostatistics, Faculty of Medicine, Hacettepe University, Ankara, Turkiye
2 shared publications Lambert T. Appiah
2 shared publicationsMichael K. Amponsah
2 shared publications
Latest Publications
- 6 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
Identifying Patients for Cardiovascular Evaluation Using Artificial Intelligence and Team-Based Care in Ghana: The H-TRIAGE Study
Background: Cardiovascular diagnostic capacity is limited in many low-resource settings. We evaluated the HeartLINK Triage for Risk-Informed Allocation and Guided Evaluation (H-TRIAGE) index, a prespecified strategy combining clinical information and AI-enabled digital auscultation to prioritize cardiovascular evaluation. Methods: In this prospective study in Ghana (February–July 2026), consecutively enrolled adults underwent a standardized assessment by trained frontline nurses and community health workers. H-TRIAGE used predefined additive symptom, vital-sign, and AI-stethoscope weights to assign Low (0–3), Intermediate (4–7), or High (≥8) Risk. Four cardiologists, blinded to H-TRIAGE, independently reviewed all participants; a fifth adjudicated disagreements. The reference standard (adjudicated indication) was a recommendation for further diagnostic testing, cardiologist-led evaluation, or both. The primary cohort comprised 5 facilities across 3 districts of the Ashanti Region; external validation used a held-out facility in a separate district of the Eastern Region. In a modeled allocation analysis, Intermediate- and High-Risk participants were considered prioritized; we calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Results: Among 3,800 participants (primary, n=3,123; external validation, n=677; median age, 52 years [IQR, 39–64]; 77.7% women), 1,707 (44.9%) had an adjudicated indication. By H-TRIAGE category, the proportion with an indication was 2.5% (Low), 87.9% (Intermediate), and 100% (High) (P for trendConclusions: H-TRIAGE accurately identified adults needing cardiologist-adjudicated evaluation, and sensitivity remained high at a geographically distinct site. Applied by frontline nurses and community health workers, it could focus scarce specialist and diagnostic capacity on the patients most likely to need it, deferring roughly half of those assessed.
- 6 November 2026
- Published by Wolters Kluwer Health in Circulation: Population Health and Outcomes
Identifying Patients for Cardiovascular Evaluation Using Artificial Intelligence and Team-Based Care in Ghana: The H-TRIAGE Study
Background: Cardiovascular diagnostic capacity is limited in many low-resource settings. We evaluated the HeartLINK Triage for Risk-Informed Allocation and Guided Evaluation (H-TRIAGE) index, a prespecified strategy combining clinical information and AI-enabled digital auscultation to prioritize cardiovascular evaluation. Methods: In this prospective study in Ghana (February–July 2026), consecutively enrolled adults underwent a standardized assessment by trained frontline nurses and community health workers. H-TRIAGE used predefined additive symptom, vital-sign, and AI-stethoscope weights to assign Low (0–3), Intermediate (4–7), or High (≥8) Risk. Four cardiologists, blinded to H-TRIAGE, independently reviewed all participants; a fifth adjudicated disagreements. The reference standard (adjudicated indication) was a recommendation for further diagnostic testing, cardiologist-led evaluation, or both. The primary cohort comprised 5 facilities across 3 districts of the Ashanti Region; external validation used a held-out facility in a separate district of the Eastern Region. In a modeled allocation analysis, Intermediate- and High-Risk participants were considered prioritized; we calculated sensitivity, specificity, positive predictive value (PPV), and negative predictive value (NPV). Results: Among 3,800 participants (primary, n=3,123; external validation, n=677; median age, 52 years [IQR, 39–64]; 77.7% women), 1,707 (44.9%) had an adjudicated indication. By H-TRIAGE category, the proportion with an indication was 2.5% (Low), 87.9% (Intermediate), and 100% (High) (P for trendConclusions: H-TRIAGE accurately identified adults needing cardiologist-adjudicated evaluation, and sensitivity remained high at a geographically distinct site. Applied by frontline nurses and community health workers, it could focus scarce specialist and diagnostic capacity on the patients most likely to need it, deferring roughly half of those assessed.
- 3 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (5) , 361-363
Artificial Intelligence–Enabled Digital Auscultation for Detecting Heart Failure With Reduced Ejection Fraction in Sub-Saharan Africa: The DAMSUN-HF Study
- 3 February 2026
- Published by Wolters Kluwer Health in Circulation
- Vol. 153 (5) , 361-363
Artificial Intelligence–Enabled Digital Auscultation for Detecting Heart Failure With Reduced Ejection Fraction in Sub-Saharan Africa: The DAMSUN-HF Study
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Invasive and Doppler Transvalvular gradients after transcatheter aortic valve replacement
Background: Differences in mean gradients after Transcatheter valve replacement (TAVR) vary depending on the valve type and the modality used to measure the gradients. Currently there is a paucity of data on the relationship between invasive and doppler derived gradients after TAVR. Purpose: We sort to assess the difference in doppler, and catheter derived aortic valve gradients after TAVR Methods: This is a single center retrospective study using consecutive patients who presented for TAVR on account of native aortic valve stenosis at our institution from May 2012 till December 2020. Patients with both intraoperative invasive and postoperative doppler derived pressure gradients were included in the analysis. Student T-test were used to compare mean gradients. Pearson's correlation test was used to examine the correlation between measured gradients. Results: A total of 587 patients were included in our study. Fifty one percent were male and 462 (78.7%) underwent TAVR with a balloon expandable valve. In the entire cohort the mean gradient measured invasively was significantly lower than those measured by echo doppler (4.48±3.25 vs. 5.57±3.11, P<0.001). There, however, was a positive correlation between invasive and doppler measured gradients (figure 1). In those who received balloon expandable valves, the invasive gradient was 4.39±3.30 and the doppler derived gradient was 5.47±3.04 (P<0.001), while in those self-expanding valves, the invasive gradient was 4.81±3.04 and doppler derived gradient was 5.94±3.36 (P<0.001). Conclusion: Post TAVR gradients were all significantly lower when measured invasively as compared to those measured using doppler. Self-expanding valves overall had higher residual gradients. Further studies are needed to assess the correlations between invasively measured gradients and clinical outcomes post TAVR. Funding Acknowledgement: Type of funding sources: None.
- 1 October 2021
- Published by Oxford University Press (OUP) in European Heart Journal
- Vol. 42 (Supplement)
Invasive and Doppler Transvalvular gradients after transcatheter aortic valve replacement
Background: Differences in mean gradients after Transcatheter valve replacement (TAVR) vary depending on the valve type and the modality used to measure the gradients. Currently there is a paucity of data on the relationship between invasive and doppler derived gradients after TAVR. Purpose: We sort to assess the difference in doppler, and catheter derived aortic valve gradients after TAVR Methods: This is a single center retrospective study using consecutive patients who presented for TAVR on account of native aortic valve stenosis at our institution from May 2012 till December 2020. Patients with both intraoperative invasive and postoperative doppler derived pressure gradients were included in the analysis. Student T-test were used to compare mean gradients. Pearson's correlation test was used to examine the correlation between measured gradients. Results: A total of 587 patients were included in our study. Fifty one percent were male and 462 (78.7%) underwent TAVR with a balloon expandable valve. In the entire cohort the mean gradient measured invasively was significantly lower than those measured by echo doppler (4.48±3.25 vs. 5.57±3.11, P<0.001). There, however, was a positive correlation between invasive and doppler measured gradients (figure 1). In those who received balloon expandable valves, the invasive gradient was 4.39±3.30 and the doppler derived gradient was 5.47±3.04 (P<0.001), while in those self-expanding valves, the invasive gradient was 4.81±3.04 and doppler derived gradient was 5.94±3.36 (P<0.001). Conclusion: Post TAVR gradients were all significantly lower when measured invasively as compared to those measured using doppler. Self-expanding valves overall had higher residual gradients. Further studies are needed to assess the correlations between invasively measured gradients and clinical outcomes post TAVR. Funding Acknowledgement: Type of funding sources: None.
- 1 December 2020
- Published by Elsevier in International Journal of Cardiology
- Vol. 320, 78-82
Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience
- 1 December 2020
- Published by Elsevier in International Journal of Cardiology
- Vol. 320, 78-82
Factors associated with bleeding events in patients on rivaroxaban for non-valvular atrial fibrillation: A real-world experience
- 7 January 2020
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 34 (11) , 778-786
Effect of intensive and standard blood pressure control on cardiovascular outcomes based on body mass index: sub-analysis of the sprint trial
The present study is a sub-analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) that aimed to evaluate the role of intensive vs. standard hypertensive treatment on cardiovascular outcomes according to the body mass indices of trial participants. SPRINT participants were categorized according to their baseline BMI values into normal (BMI ≥ 18.5 to <25), overweight (BMI ≥ 25 to 0.05). In this sub-analysis of the SPRINT trial, intensive blood pressure control had a beneficial effect in reducing the primary endpoint and all-cause mortality irrespective of the participants’ BMI.
- 7 January 2020
- Published by Springer Nature in Journal of Human Hypertension
- Vol. 34 (11) , 778-786
Effect of intensive and standard blood pressure control on cardiovascular outcomes based on body mass index: sub-analysis of the sprint trial
The present study is a sub-analysis of the Systolic Blood Pressure Intervention Trial (SPRINT) that aimed to evaluate the role of intensive vs. standard hypertensive treatment on cardiovascular outcomes according to the body mass indices of trial participants. SPRINT participants were categorized according to their baseline BMI values into normal (BMI ≥ 18.5 to <25), overweight (BMI ≥ 25 to 0.05). In this sub-analysis of the SPRINT trial, intensive blood pressure control had a beneficial effect in reducing the primary endpoint and all-cause mortality irrespective of the participants’ BMI.
- 12 November 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (2) , 413-421
Impact of chronic thrombocytopenia on in‐hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement
Background: There is little data on the impact of chronic thrombocytopenia (CTP) on outcomes after transcatheter aortic valve repair (TAVR). Most studies are from single centers and mostly focused on postprocedure thrombocytopenia.Objectives: This study sought to report on the impact of CTP (>1 year) on in‐hospital outcomes and healthcare resource utilization after TAVR.Methods: From the National Inpatient Sample (NIS) between 2012 and 2015, we identified patients with CTP who underwent TAVR. A 1:1 propensity‐matched cohort was created to examine in‐hospital outcomes in patients with and without CTP. The primary outcome was in‐hospital mortality. Secondary outcomes included postprocedure complications, length of stay, total cost, and discharge disposition.Results: A matched pair of 4,300 patients with and without CTP were identified. Patients with CTP had higher in‐hospital mortality as compared to no CTP patients (6.0 vs. 3.3%, p‐value .007), increased postprocedure hemorrhage, platelet and blood transfusion, vascular complications, postop sepsis, and acute kidney injury. With regards to resource utilization, CTP patients had a longer length of stay, higher total cost and were more likely to be discharged to a facility (34.1 vs. 27.6%) other than home (All, p‐value <.001). Subanalysis, however, revealed this difference in resource utilization was seen when patients developed postprocedure complications.Conclusion: This study demonstrated higher risk of in‐hospital mortality, perioperative complications, and healthcare resource utilization in patients with baseline CTP undergoing TAVR. Further studies are required to investigate ways to improve the management of these patients.
- 12 November 2019
- Published by Wiley in Catheterization and Cardiovascular Interventions
- Vol. 96 (2) , 413-421
Impact of chronic thrombocytopenia on in‐hospital outcomes and healthcare resource utilization after transcatheter aortic valve replacement
Background: There is little data on the impact of chronic thrombocytopenia (CTP) on outcomes after transcatheter aortic valve repair (TAVR). Most studies are from single centers and mostly focused on postprocedure thrombocytopenia.Objectives: This study sought to report on the impact of CTP (>1 year) on in‐hospital outcomes and healthcare resource utilization after TAVR.Methods: From the National Inpatient Sample (NIS) between 2012 and 2015, we identified patients with CTP who underwent TAVR. A 1:1 propensity‐matched cohort was created to examine in‐hospital outcomes in patients with and without CTP. The primary outcome was in‐hospital mortality. Secondary outcomes included postprocedure complications, length of stay, total cost, and discharge disposition.Results: A matched pair of 4,300 patients with and without CTP were identified. Patients with CTP had higher in‐hospital mortality as compared to no CTP patients (6.0 vs. 3.3%, p‐value .007), increased postprocedure hemorrhage, platelet and blood transfusion, vascular complications, postop sepsis, and acute kidney injury. With regards to resource utilization, CTP patients had a longer length of stay, higher total cost and were more likely to be discharged to a facility (34.1 vs. 27.6%) other than home (All, p‐value <.001). Subanalysis, however, revealed this difference in resource utilization was seen when patients developed postprocedure complications.Conclusion: This study demonstrated higher risk of in‐hospital mortality, perioperative complications, and healthcare resource utilization in patients with baseline CTP undergoing TAVR. Further studies are required to investigate ways to improve the management of these patients.
- 1 July 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (1) , 85-89
Effect of Transcatheter Aortic Valve Implantation on Renal Function in Patients With Previous Renal Dysfunction
- 1 July 2019
- Published by Elsevier in The American Journal of Cardiology
- Vol. 124 (1) , 85-89
Effect of Transcatheter Aortic Valve Implantation on Renal Function in Patients With Previous Renal Dysfunction
- 1 April 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (3) , 852-858
National Trends and Outcomes of Patients Bridged to Transplant With Continuous Flow Left Ventricular Assist Devices
- 1 April 2019
- Published by Elsevier in Transplantation Proceedings
- Vol. 51 (3) , 852-858
National Trends and Outcomes of Patients Bridged to Transplant With Continuous Flow Left Ventricular Assist Devices